Selected research
Market Analysis & Forecast
Global Legal Surrogacy Market Analysis and Forecast 2026-2032
Market perspective
The global Legal Surrogacy market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Legal Surrogacy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Legal Surrogacy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Legal Surrogacy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Legal Surrogacy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Legal Surrogacy include New Hope Fertility Center, IVI-RMA Global, Scanfert AVA Clinic, Bourn Hall Fertility Clinic, Nova IVI Fertility, Ovation Fertility, Bangkok IVF Center, Extraordinary Conceptions and Cardone & Associates Reproductive Medicine & Infertility, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Legal Surrogacy, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Legal Surrogacy, also provides the revenue of main regions and countries. Of the upcoming market potential for Legal Surrogacy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Legal Surrogacy revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Legal Surrogacy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Legal Surrogacy revenue, projected growth trends, production technology, application and end-user industry.
Legal Surrogacy Segment by Company
New Hope Fertility Center
IVI-RMA Global
Scanfert AVA Clinic
Bourn Hall Fertility Clinic
Nova IVI Fertility
Ovation Fertility
Bangkok IVF Center
Extraordinary Conceptions
Cardone & Associates Reproductive Medicine & Infertility
Max Healthcare
Growing Generations
Circle Surrogacy
Morpheus Life Sciences
Legal Surrogacy Segment by Type
Intrauterine Insemination (IUI)
In-vitro Fertilization (IVF)
Others
Legal Surrogacy Segment by Application
Below 35 Years
35-45 Years
Over 45 Years
Legal Surrogacy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Legal Surrogacy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Legal Surrogacy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Legal Surrogacy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Legal Surrogacy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Legal Surrogacy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Legal Surrogacy revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Intrauterine Insemination (IUI)
- In-vitro Fertilization (IVF)
- Others
Applications
- Below 35 Years
- 35-45 Years
- Over 45 Years
Companies covered
- New Hope Fertility Center
- IVI-RMA Global
- Scanfert AVA Clinic
- Bourn Hall Fertility Clinic
- Nova IVI Fertility
- Ovation Fertility
- Bangkok IVF Center
- Extraordinary Conceptions
- Cardone & Associates Reproductive Medicine & Infertility
- Max Healthcare
- Growing Generations
- Circle Surrogacy
- Morpheus Life Sciences
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Legal Surrogacy Market by Type
- 1.2.1 Global Legal Surrogacy Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Intrauterine Insemination (IUI)
- 1.2.3 In-vitro Fertilization (IVF)
- 1.2.4 Others
- 1.3 Legal Surrogacy Market by Application
- 1.3.1 Global Legal Surrogacy Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Below 35 Years
- 1.3.3 35-45 Years
- 1.3.4 Over 45 Years
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Legal Surrogacy Market Dynamics
- 2.1 Legal Surrogacy Industry Trends
- 2.2 Legal Surrogacy Industry Drivers
- 2.3 Legal Surrogacy Industry Opportunities and Challenges
- 2.4 Legal Surrogacy Industry Restraints
3 Global Growth Perspective
- 3.1 Global Legal Surrogacy Market Perspective (2021-2032)
- 3.2 Global Legal Surrogacy Growth Trends by Region
- 3.2.1 Global Legal Surrogacy Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Legal Surrogacy Market Size by Region (2021-2026)
- 3.2.3 Global Legal Surrogacy Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Legal Surrogacy Revenue by Players
- 4.1.1 Global Legal Surrogacy Revenue by Players (2021-2026)
- 4.1.2 Global Legal Surrogacy Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Legal Surrogacy Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Legal Surrogacy Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Legal Surrogacy Key Players Headquarters & Area Served
- 4.4 Global Legal Surrogacy Players, Product Type & Application
- 4.5 Global Legal Surrogacy Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Legal Surrogacy Market CR5 and HHI
- 4.6.3 2025 Legal Surrogacy Tier 1, Tier 2, and Tier 3
5 Legal Surrogacy Market Size by Type
- 5.1 Global Legal Surrogacy Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Legal Surrogacy Revenue by Type (2021-2032)
- 5.3 Global Legal Surrogacy Revenue Market Share by Type (2021-2032)
6 Legal Surrogacy Market Size by Application
- 6.1 Global Legal Surrogacy Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Legal Surrogacy Revenue by Application (2021-2032)
- 6.3 Global Legal Surrogacy Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 New Hope Fertility Center
- 7.1.1 New Hope Fertility Center Company Information
- 7.1.2 New Hope Fertility Center Business Overview
- 7.1.3 New Hope Fertility Center Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 7.1.4 New Hope Fertility Center Legal Surrogacy Product Portfolio
- 7.1.5 New Hope Fertility Center Recent Developments
- 7.2 IVI-RMA Global
- 7.2.1 IVI-RMA Global Company Information
- 7.2.2 IVI-RMA Global Business Overview
- 7.2.3 IVI-RMA Global Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 7.2.4 IVI-RMA Global Legal Surrogacy Product Portfolio
- 7.2.5 IVI-RMA Global Recent Developments
- 7.3 Scanfert AVA Clinic
- 7.3.1 Scanfert AVA Clinic Company Information
- 7.3.2 Scanfert AVA Clinic Business Overview
- 7.3.3 Scanfert AVA Clinic Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 7.3.4 Scanfert AVA Clinic Legal Surrogacy Product Portfolio
- 7.3.5 Scanfert AVA Clinic Recent Developments
- 7.4 Bourn Hall Fertility Clinic
- 7.4.1 Bourn Hall Fertility Clinic Company Information
- 7.4.2 Bourn Hall Fertility Clinic Business Overview
- 7.4.3 Bourn Hall Fertility Clinic Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 7.4.4 Bourn Hall Fertility Clinic Legal Surrogacy Product Portfolio
- 7.4.5 Bourn Hall Fertility Clinic Recent Developments
- 7.5 Nova IVI Fertility
- 7.5.1 Nova IVI Fertility Company Information
- 7.5.2 Nova IVI Fertility Business Overview
- 7.5.3 Nova IVI Fertility Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 7.5.4 Nova IVI Fertility Legal Surrogacy Product Portfolio
- 7.5.5 Nova IVI Fertility Recent Developments
- 7.6 Ovation Fertility
- 7.6.1 Ovation Fertility Company Information
- 7.6.2 Ovation Fertility Business Overview
- 7.6.3 Ovation Fertility Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 7.6.4 Ovation Fertility Legal Surrogacy Product Portfolio
- 7.6.5 Ovation Fertility Recent Developments
- 7.7 Bangkok IVF Center
- 7.7.1 Bangkok IVF Center Company Information
- 7.7.2 Bangkok IVF Center Business Overview
- 7.7.3 Bangkok IVF Center Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 7.7.4 Bangkok IVF Center Legal Surrogacy Product Portfolio
- 7.7.5 Bangkok IVF Center Recent Developments
- 7.8 Extraordinary Conceptions
- 7.8.1 Extraordinary Conceptions Company Information
- 7.8.2 Extraordinary Conceptions Business Overview
- 7.8.3 Extraordinary Conceptions Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 7.8.4 Extraordinary Conceptions Legal Surrogacy Product Portfolio
- 7.8.5 Extraordinary Conceptions Recent Developments
- 7.9 Cardone & Associates Reproductive Medicine & Infertility
- 7.9.1 Cardone & Associates Reproductive Medicine & Infertility Company Information
- 7.9.2 Cardone & Associates Reproductive Medicine & Infertility Business Overview
- 7.9.3 Cardone & Associates Reproductive Medicine & Infertility Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 7.9.4 Cardone & Associates Reproductive Medicine & Infertility Legal Surrogacy Product Portfolio
- 7.9.5 Cardone & Associates Reproductive Medicine & Infertility Recent Developments
- 7.10 Max Healthcare
- 7.10.1 Max Healthcare Company Information
- 7.10.2 Max Healthcare Business Overview
- 7.10.3 Max Healthcare Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 7.10.4 Max Healthcare Legal Surrogacy Product Portfolio
- 7.10.5 Max Healthcare Recent Developments
- 7.11 Growing Generations
- 7.11.1 Growing Generations Company Information
- 7.11.2 Growing Generations Business Overview
- 7.11.3 Growing Generations Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 7.11.4 Growing Generations Legal Surrogacy Product Portfolio
- 7.11.5 Growing Generations Recent Developments
- 7.12 Circle Surrogacy
- 7.12.1 Circle Surrogacy Company Information
- 7.12.2 Circle Surrogacy Business Overview
- 7.12.3 Circle Surrogacy Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 7.12.4 Circle Surrogacy Legal Surrogacy Product Portfolio
- 7.12.5 Circle Surrogacy Recent Developments
- 7.13 Morpheus Life Sciences
- 7.13.1 Morpheus Life Sciences Company Information
- 7.13.2 Morpheus Life Sciences Business Overview
- 7.13.3 Morpheus Life Sciences Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 7.13.4 Morpheus Life Sciences Legal Surrogacy Product Portfolio
- 7.13.5 Morpheus Life Sciences Recent Developments
8 North America
- 8.1 North America Legal Surrogacy Revenue (2021-2032)
- 8.2 North America Legal Surrogacy Revenue by Type (2021-2032)
- 8.2.1 North America Legal Surrogacy Revenue by Type (2021-2026)
- 8.2.2 North America Legal Surrogacy Revenue by Type (2027-2032)
- 8.3 North America Legal Surrogacy Revenue Share by Type (2021-2032)
- 8.4 North America Legal Surrogacy Revenue by Application (2021-2032)
- 8.4.1 North America Legal Surrogacy Revenue by Application (2021-2026)
- 8.4.2 North America Legal Surrogacy Revenue by Application (2027-2032)
- 8.5 North America Legal Surrogacy Revenue Share by Application (2021-2032)
- 8.6 North America Legal Surrogacy Revenue by Country
- 8.6.1 North America Legal Surrogacy Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Legal Surrogacy Revenue by Country (2021-2026)
- 8.6.3 North America Legal Surrogacy Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Legal Surrogacy Revenue (2021-2032)
- 9.2 Europe Legal Surrogacy Revenue by Type (2021-2032)
- 9.2.1 Europe Legal Surrogacy Revenue by Type (2021-2026)
- 9.2.2 Europe Legal Surrogacy Revenue by Type (2027-2032)
- 9.3 Europe Legal Surrogacy Revenue Share by Type (2021-2032)
- 9.4 Europe Legal Surrogacy Revenue by Application (2021-2032)
- 9.4.1 Europe Legal Surrogacy Revenue by Application (2021-2026)
- 9.4.2 Europe Legal Surrogacy Revenue by Application (2027-2032)
- 9.5 Europe Legal Surrogacy Revenue Share by Application (2021-2032)
- 9.6 Europe Legal Surrogacy Revenue by Country
- 9.6.1 Europe Legal Surrogacy Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Legal Surrogacy Revenue by Country (2021-2026)
- 9.6.3 Europe Legal Surrogacy Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Legal Surrogacy Revenue (2021-2032)
- 10.2 China Legal Surrogacy Revenue by Type (2021-2032)
- 10.2.1 China Legal Surrogacy Revenue by Type (2021-2026)
- 10.2.2 China Legal Surrogacy Revenue by Type (2027-2032)
- 10.3 China Legal Surrogacy Revenue Share by Type (2021-2032)
- 10.4 China Legal Surrogacy Revenue by Application (2021-2032)
- 10.4.1 China Legal Surrogacy Revenue by Application (2021-2026)
- 10.4.2 China Legal Surrogacy Revenue by Application (2027-2032)
- 10.5 China Legal Surrogacy Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Legal Surrogacy Revenue (2021-2032)
- 11.2 Asia Legal Surrogacy Revenue by Type (2021-2032)
- 11.2.1 Asia Legal Surrogacy Revenue by Type (2021-2026)
- 11.2.2 Asia Legal Surrogacy Revenue by Type (2027-2032)
- 11.3 Asia Legal Surrogacy Revenue Share by Type (2021-2032)
- 11.4 Asia Legal Surrogacy Revenue by Application (2021-2032)
- 11.4.1 Asia Legal Surrogacy Revenue by Application (2021-2026)
- 11.4.2 Asia Legal Surrogacy Revenue by Application (2027-2032)
- 11.5 Asia Legal Surrogacy Revenue Share by Application (2021-2032)
- 11.6 Asia Legal Surrogacy Revenue by Country
- 11.6.1 Asia Legal Surrogacy Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Legal Surrogacy Revenue by Country (2021-2026)
- 11.6.3 Asia Legal Surrogacy Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Legal Surrogacy Revenue (2021-2032)
- 12.2 SAMEA Legal Surrogacy Revenue by Type (2021-2032)
- 12.2.1 SAMEA Legal Surrogacy Revenue by Type (2021-2026)
- 12.2.2 SAMEA Legal Surrogacy Revenue by Type (2027-2032)
- 12.3 SAMEA Legal Surrogacy Revenue Share by Type (2021-2032)
- 12.4 SAMEA Legal Surrogacy Revenue by Application (2021-2032)
- 12.4.1 SAMEA Legal Surrogacy Revenue by Application (2021-2026)
- 12.4.2 SAMEA Legal Surrogacy Revenue by Application (2027-2032)
- 12.5 SAMEA Legal Surrogacy Revenue Share by Application (2021-2032)
- 12.6 SAMEA Legal Surrogacy Revenue by Country
- 12.6.1 SAMEA Legal Surrogacy Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Legal Surrogacy Revenue by Country (2021-2026)
- 12.6.3 SAMEA Legal Surrogacy Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst